MRKRNasdaqPharmaceutical PreparationsFiscal year ends December 31
Marker Therapeutics, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$1.20+0.16 (+15.38%)
Close on Oct 19, 2026
- Market cap
- $23.18M
- P/E (TTM)
- –
- Dividend yield
- –
SEC filings
40 of Marker Therapeutics's most recent filings on SEC EDGAR
| Document | Form | Period | Filed | Source |
|---|---|---|---|---|
| Current report | 8-K | Oct 19, 2026 | Oct 19, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2026 | Aug 14, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2026 | May 15, 2026 | SEC EDGAR |
| Current report | 8-K | May 1, 2026 | May 4, 2026 | SEC EDGAR |
| Proxy statement | DEF 14A | May 1, 2026 | Mar 20, 2026 | SEC EDGAR |
| Current report | 8-K | Mar 18, 2026 | Mar 19, 2026 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2025 | Mar 18, 2026 | SEC EDGAR |
| Current report | 8-K | Feb 9, 2026 | Feb 9, 2026 | SEC EDGAR |
| Current report | 8-K | Nov 14, 2025 | Nov 14, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2025 | Nov 13, 2025 | SEC EDGAR |
| Current report | 8-K | Oct 31, 2025 | Nov 5, 2025 | SEC EDGAR |
| Current report | 8-K | Oct 6, 2025 | Oct 6, 2025 | SEC EDGAR |
| Current report | 8-K | Aug 26, 2025 | Aug 26, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2025 | Aug 14, 2025 | SEC EDGAR |
| Current report | 8-K | Aug 7, 2025 | Aug 12, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 16, 2025 | Jun 17, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 6, 2025 | Jun 9, 2025 | SEC EDGAR |
| Current report | 8-K | May 20, 2025 | May 20, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2025 | May 15, 2025 | SEC EDGAR |
| Proxy statement | DEF 14A | Jun 6, 2025 | Apr 24, 2025 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2024 | Mar 31, 2025 | SEC EDGAR |
| Current report | 8-K | Mar 31, 2025 | Mar 31, 2025 | SEC EDGAR |
| Current report | 8-K | Mar 21, 2025 | Mar 27, 2025 | SEC EDGAR |
| Current report | 8-K | Feb 12, 2025 | Feb 19, 2025 | SEC EDGAR |
| Proxy statement | DEF 14A | Mar 21, 2025 | Feb 4, 2025 | SEC EDGAR |
| Current report | 8-K | Jan 24, 2025 | Jan 30, 2025 | SEC EDGAR |
| Current report | 8-K | Dec 23, 2024 | Dec 23, 2024 | SEC EDGAR |
| Current report | 8-K | Dec 19, 2024 | Dec 19, 2024 | SEC EDGAR |
| Current report | 8-K | Dec 17, 2024 | Dec 17, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2024 | Nov 14, 2024 | SEC EDGAR |
| Current report | 8-K | Nov 14, 2024 | Nov 14, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2024 | Aug 14, 2024 | SEC EDGAR |
| Current report | 8-K | Aug 14, 2024 | Aug 14, 2024 | SEC EDGAR |
| Current report | 8-K | Aug 12, 2024 | Aug 12, 2024 | SEC EDGAR |
| Current report | 8-K | Jun 6, 2024 | Jun 12, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2024 | May 15, 2024 | SEC EDGAR |
| Current report | 8-K | May 15, 2024 | May 15, 2024 | SEC EDGAR |
| Proxy statement | DEF 14A | Jun 6, 2024 | Apr 26, 2024 | SEC EDGAR |
| Current report | 8-K | Apr 8, 2024 | Apr 8, 2024 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2023 | Mar 26, 2024 | SEC EDGAR |